Dorman Products (DORM) Cash & Equivalents (2010 - 2026)

Dorman Products has reported Cash & Equivalents for 17 years, with the latest figure at $43.1 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 28.96% year-over-year to $43.1 million; the trailing twelve-month figure through Mar 2026 stood at $43.1 million (down 28.96% YoY), and the FY2025 full-year result was $49.4 million, down 13.48% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $43.1 million, down from $49.4 million in the prior quarter.
• The five-year high for Cash & Equivalents was $60.6 million in Q1 2025, with the low at $32.0 million in Q3 2023.
• Average Cash & Equivalents over 5 years is $45.5 million, with a median of $46.0 million recorded in 2022.
• Year-over-year, Cash & Equivalents slumped 67.93% in 2022 and jumped 76.03% in 2025.
• Tracing DORM's Cash & Equivalents over 5 years: stood at $46.0 million in 2022, then dropped by 20.03% to $36.8 million in 2023, then soared by 55.2% to $57.1 million in 2024, then declined by 13.48% to $49.4 million in 2025, then fell by 12.91% to $43.1 million in 2026.
• The last three Cash & Equivalents figures came in at $43.1 million (Q1 2026), $49.4 million (Q4 2025), and $55.5 million (Q3 2025), per Business Quant data.

Peer Comparison